You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Eighteen researchers call for a temporary stop to all clinical uses of human germline editing in a piece appearing in Nature.
Bar-Ilan University researchers find that sleeping could help fix DNA damage that accumulates during the day in neurons, according to the Guardian.
In PLOS this week: potential cystic fibrosis modifiers, potential kidney cancer survival signature, and more.
The deals cover the Finnish diagnostic company's Amplidiag and Novodiag lines of infectious disease and antibiotic resistance testing products.
Emedgene, which makes AI-based, automated genomic interpretation software, will use the Series A funding to expand its US sales operations.
The World Health Organization has announced the members of its gene-editing committee, according to NPR.
Loss-of-function mutations in PADI3, which was previously linked to uncombable hair syndrome, appear to be involved in central centrifugal cicatricial alopecia.
Based on the results, the UAE-based lab would become Biocept's first customer to use the kits clinically, accepting samples from the Middle East, Africa, and Asia.
In Science this week: mechanisms of trait adaptation in wild mice, and more.
In a bid to amass hard-to-trace gift cards from a refer-a-friend program, hackers ordered 2,400 DNA ancestry testing kits for strangers, according to USA Today.
Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.
Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.
Stat News reports some health tech startups are laying off or furloughing workers.
In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.